EP3999038
Samsetningar af hjartavöðvaliðs-hindra til gjafar um munn
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.7.2020EP published:
10.1.2024EP application number:
20753563.4
EP translation filed:
11.3.2024Grant published:
15.4.2024EPO information:
European Patent Register
Max expiry date:
15.7.2040Expiry date:
15.7.2026Next due date:
31.7.2026
Title in English:
CARDIAC SARCOMERE INHIBITOR ORAL FORMULATIONSLanguage of the patent:
English
Timeline
Today
16.7.2020EP application
10.1.2024EP Publication
11.3.2024Translation submitted
15.4.2024Registration published
15.7.2026Expires
Owner
Name:
Cytokinetics, Inc.Address:
350 Oyster Point Blvd, South San Francisco CA 94080, US
Inventor
Name:
QIAO, ChunshengAddress:
Palo Alto, California 94306, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962875358 PDate:
17.7.2019Country:
US
Classification
Categories:
A61K 9/16, A61K 9/20, A61K 9/28, A61K 31/4178, A61P 9/04
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 7.6.2024
Expires: 15.7.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 7.7.2025
Expires: 15.7.2026
Payer: Árnason Faktor ehf.